Financial News
Bluebird Bio (NQ: BLUE )
1.220
+0.020
(+1.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Bluebird Bio
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20240229085127_bluebird-bio-stock-signals-potential-to-be-a-multi.jpg)
![](https://www.investors.com/wp-content/uploads/2022/10/Stock-beamtherapeutics-01-adobe.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240226142303_bluebird-bio-how-to-play-leaps-options-for-growth.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240226141222_bluebird-stock-is-ripe-for-a-400-institutional-sho.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/27/image38.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20240225182115_is-crispr-therapeutics-the-nvidia-of-gene-editing.jpg)
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg)
![](https://g.foolcdn.com/editorial/images/761882/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Gene-therapy.jpeg?width=1200&height=800&fit=crop)
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/760285/patient-sitting-on-hospital-bed.jpg)
2 Red Flags for Bluebird Bio Stock
January 10, 2024
Via The Motley Fool
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://mms.businesswire.com/media/20240108221653/en/670463/5/bluebird_logo.jpg)
![](https://g.foolcdn.com/editorial/images/759566/investor-looks-at-book-with-consternation.jpg)
![](https://mms.businesswire.com/media/20240102188681/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/757293/bluebird_bio_blue_biotechnology_biotech_stocks_stock.jpg)
![](https://g.foolcdn.com/editorial/images/758514/businessman-checking-his-phone.jpg)
![](https://g.foolcdn.com/editorial/images/758348/patient-sitting-on-hospital-bed.jpg)
![](https://g.foolcdn.com/editorial/images/758692/scientist-examines-samples-with-microscope-while-in-laboratory.jpg)
![](https://g.foolcdn.com/editorial/images/758888/a-person-delivering-a-presentation-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/20/image44.jpg?width=1200&height=800&fit=crop)
S&P 500 Edges Lower; General Mills Cuts Sales Forecast
December 20, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/20/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/20/crude_oil3_-_logo.jpg?width=1200&height=800&fit=crop)
Crude Oil Rises 1%; US Current Account Gap Narrows In Q3
December 20, 2023
Via Benzinga
Topics
Stocks
![](https://cdn.benzinga.com/files/images/story/2023/12/20/image19.jpg?width=1200&height=800&fit=crop)
US Stocks Mostly Lower; FedEx Earnings Miss Estimates
December 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/20/blur-1853262_1920-14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/20/image33.jpeg?width=1200&height=800&fit=crop)
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
December 20, 2023
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.